Reviva Pharmaceuticals Holdings Inc. (RVPH): Narxning sotuvga nisbati
Reviva Pharmaceuticals (RVPH) daromadlari Brinzolazine dori vositasining kelgusidagi tijoratlashtirilishiga asoslangan bo'lib, bu vaqtincha moliyaviy xatarlarni yuzaga keltiradi. GURU.Markets grafigidagi metrik qiymatiga ega bo'lgan sotuvlarga nisbatan narx koeffitsiyenti bozor kutganlarini aks ettiradi. Ventur kapitali qimmat klinika sinovlari va patent cheklovlari to'siqlarini yengib o'tishga yordam beradi, xavfsiz Brinlarikazine dori vositasiga tikilgan tikish esa kompaniya uchun faol o'sishni ta'minlaydi.
%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_RVPH_-_Reviva-Pharmaceuticals_-_PS-Multiple "RVPH - Reviva Pharmaceuticals, Inc. Bozor kapitallashuvining daromadga nisbati 04.07.2022 - 14.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Reviva Pharmaceuticals Holdings (RVPH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Reviva Pharmaceuticals|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Reviva Pharmaceuticals, Inc.|RVPH - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Reviva Pharmaceuticals Holdings|RVPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Reviva Pharmaceuticals|Shoshilinch likvidlik revivapharma.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
RVPH - Sof daromad|Prognoz qilingan kelajakdagi foyda Reviva Pharmaceuticals|RVPH - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Reviva Pharmaceuticals Holdings Inc.|RVPH - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Reviva Pharmaceuticals Holdings|RVPH - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Reviva Pharmaceuticals|RVPH - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi revivapharma.com|RVPH - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Reviva Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:RVPH revivapharma.com
Antipsixotik dori vositalari uchun klinik sinovlarning muvaffaqiyati Reviva Pharmaceuticals (RVPH) kompaniyasiga raqobatbardosh bozor ustunligi va premium narx belgilash imkoniyatini beradi. Kompaniyaning P/S grafigini tahlil qilish orqali investor bozor kapitalizatsiyasining haqiqiy savdo hajmidagi nisbatini baholaydi. Ushbu koeffitsient bir dollar daromadga qancha dollar biznes qiymati tegishli ekanligini aniqlab, aktiv haddan tashqari qimmat yoki arzon baholanganini ko'rsatadi. Ushbu ko'rsatkichning barqarorligi biofarmatsevtika sektoridagi biznes modelining fundamental chidamliligini tasdiqlaydi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|vikingtherapeutics.com (VKTX) - P/S multiplikatori|Narxning daromadga nisbati Supernus|CPRX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Kapitalizatsiyaning daromadga nisbati Harmony Corp HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning daromadga nisbati|AVXL: P/S multiplikatori|Sotuvga nisbatan narx CeriBell EEG (CBLL)|Kapitalizatsiyaning daromadga nisbati PRTA|P/S multiplikatori Alector Therapeutics|Kapitalizatsiyaning daromadga nisbati ANNX (Annexon)|Kapitalizatsiyaning sotish hajmiga nisbati OMER|P/S multiplikatori NGNE (Neurogene Corp)|Narx/daromad koeffitsiyenti AC Immune Inc (ACIU)|Voyager Therapeutics - P/S multiplikatori|neumoratx.com (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - P/S multiplikatori|Narxning daromadga nisbati Alpha Cognition Inc|Narxning daromadga nisbati CGTX|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|Narx/daromad koeffitsiyenti cassavasciences.com|Narxning daromadga nisbati Assertio ASRT|Bozor kapitallashuvining daromadga nisbati COYA|VTGN: Kapitalizatsiyaning daromadga nisbati|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals (ABOS) - Narxning daromadga nisbati|Narxning sotuvga nisbati CRVO (cervomed.com)|ATHE (Alterity Therapeutics Ltd.) - P/S multiplikatori|CLNN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Sotuvga nisbatan narx|GRCE: Kapitalizatsiyaning daromadga nisbati|AIFF - P/S multiplikatori|anewmeds.com (KLTO) - Narxning daromadga nisbati|NeuroSense Therapeutics Ltd. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati MetaVia Inc.|Sotuvga nisbatan narx neuraxis.com NRXS|Narxning daromadga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NEUP (Neuphoria Therapeutics)|Minerva (NERV) - Sotuvga nisbatan narx|ATHA: Kapitalizatsiyaning daromadga nisbati|ADXN: Narxning daromadga nisbati|ALZN: P/S multiplikatori|CYCN - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PTIX|Narxning daromadga nisbati KTTA|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|longboardpharma.com - Bozor kapitallashuvining daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|P/S multiplikatori NKGen Biotech Inc|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN - Kapitalizatsiyaning daromadga nisbati|Vigil Neuro - P/S multiplikatori|WENA - P/S multiplikatori|CERE: P/S multiplikatori
